An Open-label Study to Investigate the Clinical Efficacy of Different Dosing Regimens of Efgartigimod IV in Patients With Generalized Myasthenia Gravis
Clinical trial NCT04980495 · COMPLETED
Trial details
- NCT number
- NCT04980495
- Sponsor
- argenx
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-16
- Primary completion
- 2023-08-24
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.